Novo Nordisk to bolster API production with multi-billion kroner investment in Denmark
Today, Novo Nordisk revealed its intention to channel in excess of DKK 42 billion (USD 6 billion) from 2023 onwards into the expansion of its Kalundborg, Denmark manufacturing operations.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.